本页面由Tiger Trade Technology Pte. Ltd.提供服务

Adaptive Biotechnologies Corp

13.71
-0.3700-2.63%
盘后13.68-0.0300-0.22%18:33 EDT
成交量:140.53万
成交额:1,910.56万
市值:21.08亿
市盈率:-34.96
高:14.06
开:13.95
低:13.39
收:14.08
52周最高:20.76
52周最低:6.77
股本:1.54亿
流通股本:1.17亿
量比:0.72
换手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):-0.3922
每股收益(LYR):-0.3922
净资产收益率:-27.82%
总资产收益率:-6.79%
市净率:9.64
市盈率(LYR):-34.96

数据加载中...

2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/11

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/11/05

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/11

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

重要事件披露

Form 8-K - Current report
2024/06/11

重要事件披露

Form 8-K - Current report
2024/05/28

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/09

重要事件披露

Form 8-K - Current report